Atlas Trials

Study on the Biomarkers of Anti-VEGF Treatment for Choroidal Neovascularization

Clinical trial NCT06243406 · UNKNOWN

Trial details

NCT number
NCT06243406
Sponsor
Beijing Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Choroidal Neovascularization
Start date
2024-02-10
Primary completion
2024-10-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.